Literature DB >> 30488620

Editorial: treating strictures in inflammatory bowel disease-authors' reply.

Florian Rieder1,2, Brian G Feagan3,4,5, Vipul Jairath3,4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30488620      PMCID： PMC7549888          DOI： 10.1111/apt.15032

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   9.524


× No keyword cloud information.
  4 in total

1.  Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease.

Authors:  Reena Khanna; Guangyong Zou; Geert D'Haens; Paul Rutgeerts; J W D McDonald; Marco Daperno; Brian G Feagan; William J Sandborn; Elena Dubcenco; Larry Stitt; Margaret K Vandervoort; Allan Donner; Allison Luo; Barrett G Levesque
Journal:  Gut       Date:  2015-05-02       Impact factor: 23.059

2.  An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease.

Authors:  F Rieder; D Bettenworth; C Ma; C E Parker; L A Williamson; S A Nelson; G van Assche; A Di Sabatino; Y Bouhnik; R W Stidham; A Dignass; G Rogler; S A Taylor; J Stoker; J Rimola; M E Baker; J G Fletcher; J Panes; W J Sandborn; B G Feagan; V Jairath
Journal:  Aliment Pharmacol Ther       Date:  2018-06-19       Impact factor: 8.171

3.  Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.

Authors:  Gary R Lichtenstein; Allan Olson; Suzanne Travers; Robert H Diamond; Donny M Chen; Michelle L Pritchard; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Stephen B Hanauer; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2006-05       Impact factor: 10.864

4.  Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

Authors:  Yoram Bouhnik; Franck Carbonnel; David Laharie; Carmen Stefanescu; Xavier Hébuterne; Vered Abitbol; Maria Nachury; Hedia Brixi; Arnaud Bourreille; Laurence Picon; Anne Bourrier; Matthieu Allez; Laurent Peyrin-Biroulet; Jacques Moreau; Guillaume Savoye; Mathurin Fumery; Stephane Nancey; Xavier Roblin; Romain Altwegg; Guillaume Bouguen; Gilles Bommelaer; Silvio Danese; Edouard Louis; Magaly Zappa; Jean-Yves Mary
Journal:  Gut       Date:  2017-01-24       Impact factor: 23.059
  4 in total
  1 in total

Review 1.  Novel mechanisms and clinical trial endpoints in intestinal fibrosis.

Authors:  Jie Wang; Sinan Lin; Jonathan Mark Brown; David van Wagoner; Claudio Fiocchi; Florian Rieder
Journal:  Immunol Rev       Date:  2021-05-16       Impact factor: 10.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.